#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arginase deficiency Osteosarcoma Thromboangiitis obliterans Orthostatic hypotension General anaesthesia Myocarditis Neutropenia Crigler-Najjar syndrome Malignant oligodendroglioma Leukocyte adhesion deficiency type I VEXAS syndrome Familial hypertriglyceridaemia Osteopetrosis Netherton's syndrome Cardiac sarcoidosis More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome – Trials in Disease Chondrosarcoma metastatic – Trials in Disease Brain stem glioma Behcet’s syndrome – Trials in Disease Antithrombin III deficiency – Basic Information Gaucher’s disease type III – Basic Information Angelman’s syndrome – Life with Disease Primary immunodeficiency syndrome – Trials in Disease Wolfram syndrome – Basic Information Lymphatic malformation More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefuroxime Axetil 4-IODOPHENYLALANINE I-131 ALN-4324 SAR445399 Fingolimod Hydrochloride Rimegepant Human Vaccinia Immunoglobulin Calcium Chloride Vutrisiran Clenbuterol Hydrochloride Setmelanotide Opevesostat Tosilate GSKVX000000034795 Melatonin Deutivacaftor Acetylsalicylic Acid Ph. Eur. Ivabradine Hydrochloride Filgrastim Evolocumab Dapagliflozin Propanediol More therapies…

    Learn about Your Condition

    Hepatocellular carcinoma Retinal artery occlusion Pterygium Neck pain Hyperlipidaemia Endometrial cancer stage IV Vaginal haemorrhage Anaemia of chronic disease Hyperparathyroidism primary Urinary incontinence Retroperitoneal fibrosis Cystic fibrosis Vesicoureteric reflux Glycogen storage disorder Muscular dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Synovial sarcoma

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ttf-Ngr
    Germany

  • Study on Pasireotide for Patients with Synovial Sarcoma and Desmoplastic Small Round Cell Tumor

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Desmoplastic small round cell tumour
    • Synovial sarcoma
    Investigated Drugs:
    • Pasireotide
    Germany

  • Long-Term Follow-Up Study for Patients with Myxoid/Round Cell Liposarcoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Synovial Sarcoma Treated with Letetresgene Autoleucel

    Recruiting

    1 1 1
    Investigated Drugs:
    • Letetresgene Autoleucel
    France Italy The Netherlands Spain

  • Study of Personalized Peptide Vaccine with PERVI-FUS, PERVI-NEO, and 11902A for Children and Young Adults with Metastatic Fusion-Driven Sarcomas

    Recruiting

    2 1 1
    Investigated Diseases:
    • Alveolar rhabdomyosarcoma
    • Synovial sarcoma
    • Ewing’s sarcoma
    Investigated Drugs:
    • 11902A
    • Pervi-Fus
    • Pervi-Neo
    Germany

  • Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Nephroblastoma
    • Desmoplastic small round cell tumour
    • Rhabdoid tumour
    Investigated Drugs:
    • 7-Ethyl-10-Hydroxycamptothecin
    Spain

  • Study of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Extraskeletal myxoid chondrosarcoma
    • Follicle centre lymphoma diffuse small cell lymphoma
    • Limb reduction defect
    Investigated Drugs:
    • Tazemetostat
    France Poland
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!